In addition to inhibition of sialidase, the compound also inhibited PLA2 which has also been implicated in anemia development during the infection [9] but, no pronounced effect was observed since the Ki value was >9000 μM suggesting the compound is more active against T. congolense sialidase than PLA2. The gene discussed is TBXT; the disease is anemia (phenotype).